Resources

Advisers' Recommended Reading

View all publications

Thrombosis News

  • FDA: Doctors Should Look For Alternatives To Blood Clot Drug View description The FDA posted a letter to its Web site on Wednesday from Celgene Corp. warning users of blood-clot busting drug Innohep that new findings suggest the drug may lead to death in the elderly.
  • Plavix Blood Thinner Effectiveness Influenced By Gene Variants View description Two studies of heart patients showed that the blood thinner clopidogrel (brand name Plavix) was less effective in carriers of certain variants of a gene known to affect how the drug prevents blood clots than non-carriers.
  • This year’s most interesting hematology stories View description Two articles concerning anticoagulants are worth emphasizing. In February, Kenneth Bauer, MD, editorialized on a new oral anti-Factor Xa agent, rivaroxaban (Xarelto, Bayer/Ortho-McNeil). That it soon may replace parenteral anticoagulants in acute situations, as well as warfarin in more chronic conditions seems likely.
  • West Penn Testing Possible Warfarin Replacement View description “Rivaroxaban shows great promise as a replacement for warfarin, a medication that has been the only oral anticoagulant for the last 60 years, and can be difficult to dose correctly,” said Dr. Margaret Kennedy who is the principal investigator in the two trials.
View all news

Recommended Websites

  • ThrombosisManagement CME View description Registry of federally and privately supported clinical trials conducted in the United States and around the world
  • ClinicalTrialResults.org View description Registry of federally and privately supported clinical trials conducted in the United States and around the world
  • ClinicalTrials.gov View description Registry of federally and privately supported clinical trials conducted in the United States and around the world
View all websites